AbCellera Results Presentation Deck

Q2 2021 BUSINESS UPDATE COPYRIGHT © ABCELLERA 11 CENTRALIZE INNOVATION TO MAKE DRUG DISCOVERY FASTER, MORE EFFICIENT & MORE COST EFFECTIVE. Genito Urinary System Infectious Disease Autoimmune Diseases Allergic Inflammation Single Chain Antibodies (scFvs) CNS-Delivered Antiibodies Public Health Oncology Venture Capital IgGs, IgMs, IgAs THERAPEUTIC AREAS Equity MODALITIES PARTNER TYPES Private & Small Cap Biotech DEAL TYPES Royalties & Milestones ABCELLERA Neuro- degeneration Bispecific Antibodies Large & Mid Cap Biotech Option to Invest Global Pharma Other Pain Ophthalmology CAR-T Cell Conjugates Radioisotope Conjugates Women's Health Cardiovascular

View entire presentation